Shortly after the emergence of coronavirus disease 2019 (COVID-19) in late 2019, clinicians
rapidly recognized an apparent association between the disease and both arterial and …

A hypercoagulable state associated with coronavirus disease 2019 (COVID-19) has been
well documented and is believed to be strongly supported by a proinflammatory state. The …

At this time last year, it was farfetched if not impossible to think of the immense changes and
challenges to people and the society in 2020. Social distancing has become the norm in …

Clinical, laboratory, and autopsy findings support an association between coronavirus
disease-2019 (COVID-19) and thromboembolic disease. Acute COVID-19 infection is …

Background COVID‐19 disease‐related coagulopathy and thromboembolic complication,
an important aspect of the disease pathophysiology, are frequent and associated with poor …

Introduction: COVID-19 induces a pro-thrombotic state as evidenced by microvascular
thrombi in the renal and pulmonary vasculature. Therapeutic anticoagulation in COVID-19 …

The coronavirus disease 2019 (COVID-19) shows high incidence of thromboembolic events
in humans. In the present study, we aimed to evaluate if anticoagulation prior to COVID-19 …

The Coronavirus Disease 2019 (COVID-19) pandemic has resulted in significant morbidity
and mortality worldwide. Although initial reports concentrated on severe respiratory illness …

A higher risk of thrombosis has been described as a prominent feature of coronavirus
disease 2019 (COVID-19). This systematic review synthesizes current data on thrombosis …

Background Thromboembolic events are common complications of COVID-19. Clinical study
results on safety and efficacy of anticoagulation in COVID-19 are controversial. Material and …